Coloplast Market Risk Adjusted Performance
| CBHD Stock | | | 57.56 -0.86 -1.47% |
The Market Risk Adjusted Performance signal for Coloplast AS reflects patterns observed in trading data. All inputs are based on actual trading observations from supported exchanges. Indicator reliability depends on the continuity of available trading data. Coloplast has a market cap of 13.17 B, operating margin of 26.27%, ROE of 27.26%.
Trending Equities adds portfolio-level perspective. The portfolio structure is presented for analytical context. The view is constructed from recorded portfolio positions. Reported data is organized for reference and does not imply a course of action. A position in Coloplast AS appears within the mix. The allocation reflects this within the position set. Position sizing reflects the allocation methodology applied to the portfolio. The information is presented without directional commentary. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in inflation.
Coloplast AS has current Market Risk Adjusted Performance of
-19.26.
MRAP | = | ER[a] + (1/BETA - 1) | X | ER[a] - RFR) |
| = | -19.26 | |
| ER[a] | = | Expected return on investing in Coloplast |
| RFR | = | Risk Free Rate of return. Typically T-Bill Rate |
| BETA | = | Beta of the asset with market or selected benchmark. |
Market Risk Adjusted Performance Peers Comparison
Market Risk Adjusted Performance Relative To Other Indicators
Coloplast AS is rated
below average for market risk adjusted performance relative to top peers. It is currently under evaluation for maximum drawdown relative to top peers .
Other Technical Indicators